Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,542
Total Claims
$1.4M
Drug Cost
354
Beneficiaries
$3,925
Cost/Patient
Risk Score Breakdown 3/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-89%
Opioid rate vs peers
0.3% vs 2.6% avg
+268%
Cost per patient vs peers
$3,925 vs $1,068 avg
+138%
Brand preference vs peers
21.4% vs 9.0% avg
Opioid Prescribing
0.3%
Opioid Rate
28
Opioid Claims
$106
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,991 claims · $1.2M
Generic: 7,317 claims · $199K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phos/Metformin Hcl | 112 | $84K |
| Apixaban | 78 | $74K |
| Dolutegravir/Rilpivirine | 20 | $71K |
| Empagliflozin | 61 | $51K |
| Dapagliflozin Propanediol | 47 | $45K |
| Dulaglutide | 21 | $43K |
| Finerenone | 49 | $40K |
| Sitagliptin Phosphate | 48 | $39K |
| Sitagliptin Phos/Metformin Hcl | 53 | $35K |
| Semaglutide | 28 | $34K |
| Budesonide/Formoterol Fumarate | 70 | $34K |
| Empagliflozin/Linagliptin | 42 | $33K |
| Linaclotide | 52 | $29K |
| Rivaroxaban | 35 | $28K |
| Diclofenac Sodium | 148 | $26K |
Prescribing Profile
Patient Profile
71
Avg Age
75%
Female
1.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data